905 related articles for article (PubMed ID: 12107422)
1. Antihypertensive persistence and drug class.
Marentette MA; Gerth WC; Billings DK; Zarnke KB
Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
[TBL] [Abstract][Full Text] [Related]
2. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study.
Bourgault C; Sénécal M; Brisson M; Marentette MA; Grégoire JP
J Hum Hypertens; 2005 Aug; 19(8):607-13. PubMed ID: 15920457
[TBL] [Abstract][Full Text] [Related]
3. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000.
Al Khaja KA; Sequeira RP
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):741-8. PubMed ID: 16342299
[TBL] [Abstract][Full Text] [Related]
4. Long-term persistence with antihypertensive drugs in new patients.
Degli Esposti E; Sturani A; Di Martino M; Falasca P; Novi MV; Baio G; Buda S; Volpe M
J Hum Hypertens; 2002 Jun; 16(6):439-44. PubMed ID: 12037702
[TBL] [Abstract][Full Text] [Related]
5. Treating hypertension. Are the right drugs given to the right patients?
Beaulieu MD; Dufresne L; LeBlanc D
Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
[TBL] [Abstract][Full Text] [Related]
6. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
[TBL] [Abstract][Full Text] [Related]
7. The effect of selected patient's characteristics on the choice of antihypertensive medication in the elderly in Slovakia.
Wawruch M; Dukat A; Murin J; Wsolova L; Kuzelova M; Macugova A; Wimmer G; Shah R
Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1199-205. PubMed ID: 19718707
[TBL] [Abstract][Full Text] [Related]
8. Stepped care for hypertension: are the assumptions valid?
Caro JJ
J Hypertens Suppl; 1997 Dec; 15(7):S35-9. PubMed ID: 9532519
[TBL] [Abstract][Full Text] [Related]
9. Persistence with treatment in newly treated middle-aged patients with essential hypertension.
Perreault S; Lamarre D; Blais L; Dragomir A; Berbiche D; Lalonde L; Laurier C; St-Maurice F; Collin J
Ann Pharmacother; 2005 Sep; 39(9):1401-8. PubMed ID: 16076920
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
[TBL] [Abstract][Full Text] [Related]
11. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study.
Erkens JA; Panneman MM; Klungel OH; van den Boom G; Prescott MF; Herings RM
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):795-803. PubMed ID: 16178043
[TBL] [Abstract][Full Text] [Related]
12. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy.
Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):587-93. PubMed ID: 16586465
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in ontario.
Friedman O; McAlister FA; Yun L; Campbell NR; Tu K;
Am J Med; 2010 Feb; 123(2):173-81. PubMed ID: 20103027
[TBL] [Abstract][Full Text] [Related]
14. The quality of arterial hypertension treatment in cardiology service in Kosovo--a single center study.
Bajraktari G; Sylejmani X; Thaçi K; Elezi S; Ndrepepa G
Anadolu Kardiyol Derg; 2009 Apr; 9(2):96-101. PubMed ID: 19357050
[TBL] [Abstract][Full Text] [Related]
15. Current status of antihypertensive prescription and associated blood pressure control in Japan.
Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
[TBL] [Abstract][Full Text] [Related]
16. [Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region].
Lapeyre-Mestre M; Sulem P; Chastan E; Niezborala M; Briant D; Jansou P; Sanguignol F; Montastruc JL
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):925-9. PubMed ID: 10989731
[TBL] [Abstract][Full Text] [Related]
17. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns.
Rywik TM; Rywik SL; Korewicki J; Broda G; Sarnecka A; Drewla J
Int J Cardiol; 2004 Jun; 95(2-3):177-84. PubMed ID: 15193817
[TBL] [Abstract][Full Text] [Related]
18. [Treatment patterns of hypertension in 1996. Data from the Quebec Family Practice, University of Sherbrooke registry].
Laplante P; Niyonsenga T; Delisle E; Vanasse N; Vanasse A; Grant AM; Xhignesse M
Can Fam Physician; 1998 Feb; 44():306-12. PubMed ID: 9512834
[TBL] [Abstract][Full Text] [Related]
19. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
Román O; Cuevas G; Bunout D
Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
[TBL] [Abstract][Full Text] [Related]
20. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
